Nanomaterials in Drug Delivery Systems: Challenges and Perspectives

Nanomaterials have emerged as a transformative technology in drug delivery systems, offering unique properties that enhance therapeutic efficacy and safety. Their small size, high surface area, and ability to be engineered for targeted delivery enable improved solubility, controlled release, and reduced side effects of pharmaceuticals. This paper discusses various types of nanomaterials used in drug delivery, including nanoparticles, liposomes, and dendrimers, highlighting their mechanisms of action and advantages over conventional delivery methods. Despite their potential, the integration of nanomaterials in clinical applications faces several challenges, including manufacturing scalability, regulatory hurdles, bio distribution unpredictability, and concerns regarding toxicity and biocompatibility. Additionally, complex interactions between nanomaterials and biological systems pose significant hurdles. The future of nanomaterials in drug delivery lies in innovative approaches, such as personalized medicine and biodegradable carriers, necessitating continued interdisciplinary research and collaboration. This review aims to provide insights into the current status and future perspectives of nanomaterials in drug delivery, emphasizing the importance of overcoming existing challenges to fully harness their potential in enhancing patient outcomes.